Industry Insights · Device Segments & Clinical
The century-long catheter infection war: Foley design, CAUTI and the coating path
Nearly a century after the Foley catheter, it has saved countless lives and opened one of the largest gaps for hospital infection.
A simple, great design
At the 1935 AUA meeting, Foley's dual-lumen balloon catheter solved fixation with 'a small balloon inflated to anchor at the bladder neck' — simple and elegant; before it, catheterization was a painful, often infectious ordeal.
The Pandora's box it opened
The body resists infection via urethral sphincter closure and periodic urine flushing; an indwelling catheter breaks both. ~15–25% of inpatients and up to 61% in ICU need catheterization; CAUTI is 20–40% of hospital infections, near 30 days indwelling almost no one is spared, and a notable share of hospital bloodstream infections relate to the urinary tract.
Why 'not won yet'
A century on, CAUTI persists: bacterial biofilm, long indwelling and huge patient numbers mean protocol alone can't solve it. At the materials level, lubricity (less insertion trauma) and antimicrobial/anti-biofilm coatings remain active directions.
The BIO angle
FAQ
What is CAUTI?
Catheter-Associated Urinary Tract Infection — a hospital infection from indwelling urinary catheters, 20–40% of hospital infections.
Why does indwelling catheterization invite infection?
The catheter breaks both the urethral sphincter closure and urine flushing barriers and fosters bacterial biofilm; the longer indwelling, the higher the risk.
Can coatings reduce catheter infection?
Lubricious coatings cut insertion trauma; antimicrobial/anti-biofilm coatings help inhibit colonization. Both are key materials directions for CAUTI, alongside protocol.
Related reading
- Nystagmus Device Approved: After the Breakthrough, Commercialization Begins | BIO Insights
- A Double Breakthrough in Minimally Invasive Glaucoma Care: RF Ablation and Suprachoroidal Drainage | BIO Insights
- AI Medical Devices 2025: a RMB52.5bn Market, Ten Leaders, and Why Materials Still Matter | BIO Insights
Note: an original analysis compiled from public industry information; figures and conclusions per official/original sources. Not investment advice.
Building in China's medical-device market?
From advanced medical silicone/polymers to material selection, regulatory and supply, BIO helps global and local partners move from selection to landed supply in China.